Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™, ≥99% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 18 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects
| Canonical Smiles | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+] |
|---|---|
| IUPAC Name | disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
| InChIKey | PLCQGRYPOISRTQ-FCJDYXGNSA-L |
| INCHI | 1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1 |
| Isomeric SMILES | C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+] |
| Alternate CAS | 2392-39-4 |
| Molecular Weight | 516.4 |
| Reaxy-Rn | 29316793 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=29316793&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Subclass | Pregnane steroids |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
| Alternative Parents | 20-oxosteroids 11-beta-hydroxysteroids 17-hydroxysteroids 3-oxo delta-1,4-steroids Halogenated steroids Delta-1,4-steroids Glycerone phosphates Alkyl phosphates Tertiary alcohols Alpha-hydroxy ketones Secondary alcohols Cyclic alcohols and derivatives Cyclic ketones Fluorohydrins Organic metal halides Alkyl fluorides Hydrocarbon derivatives Organofluorides Organic sodium salts Organic oxides |
| Molecular Framework | Aliphatic homopolycyclic compounds |
| Substituents | Progestogin-skeleton - 20-oxosteroid - 3-oxo-delta-1,4-steroid - 3-oxosteroid - 9-halo-steroid - Halo-steroid - Hydroxysteroid - Oxosteroid - 11-beta-hydroxysteroid - 11-hydroxysteroid - 17-hydroxysteroid - Delta-1,4-steroid - Glycerone phosphate - Alkyl phosphate - Phosphoric acid ester - Organic phosphoric acid derivative - Tertiary alcohol - Alpha-hydroxy ketone - Cyclic alcohol - Secondary alcohol - Cyclic ketone - Fluorohydrin - Ketone - Halohydrin - Organic metal halide - Organic alkali metal salt - Hydrocarbon derivative - Organic oxide - Organohalogen compound - Organic oxygen compound - Organofluoride - Carbonyl group - Organooxygen compound - Alkyl halide - Alkyl fluoride - Alcohol - Organic salt - Organic sodium salt - Aliphatic homopolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
| External Descriptors | organic sodium salt |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 09, 2026 | D129705 | |
| Certificate of Analysis | Mar 16, 2026 | D129705 | |
| Certificate of Analysis | Mar 16, 2026 | D129705 | |
| Certificate of Analysis | Feb 06, 2026 | D129705 | |
| Certificate of Analysis | Feb 06, 2026 | D129705 | |
| Certificate of Analysis | Feb 06, 2026 | D129705 | |
| Certificate of Analysis | Feb 06, 2026 | D129705 | |
| Certificate of Analysis | Aug 12, 2025 | D129705 | |
| Certificate of Analysis | Apr 25, 2025 | D129705 | |
| Certificate of Analysis | Apr 25, 2025 | D129705 | |
| Certificate of Analysis | Apr 25, 2025 | D129705 | |
| Certificate of Analysis | Apr 25, 2025 | D129705 | |
| Certificate of Analysis | May 20, 2024 | D129705 | |
| Certificate of Analysis | May 20, 2024 | D129705 | |
| Certificate of Analysis | May 20, 2024 | D129705 | |
| Certificate of Analysis | May 20, 2024 | D129705 | |
| Certificate of Analysis | May 20, 2024 | D129705 | |
| Certificate of Analysis | Sep 12, 2022 | D129705 | |
| Certificate of Analysis | Sep 12, 2022 | D129705 | |
| Certificate of Analysis | Sep 12, 2022 | D129705 | |
| Certificate of Analysis | Sep 12, 2022 | D129705 | |
| Certificate of Analysis | Sep 12, 2022 | D129705 |
| Solubility | DMSO <1 mg/mL Water 103 mg/mL Ethanol <1 mg/mL |
|---|---|
| Molecular Weight | 516.400 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 516.13 Da |
| Monoisotopic Mass | 516.13 Da |
| Topological Polar Surface Area | 147.000 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 961.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 3 |
| 1. Chong Zhang, Fen Zeng, Zhengyang Fan, Zhen He, Liang Tai, Qiang Peng, Yixin Zhang, Zhenhua Chao, Wenning Jiang, Lingyun Jia, Lulu Han. (2023) An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease. Acta Biomaterialia, [PMID:37597682] [10.1016/j.actbio.2023.08.020] |
| 2. Jing Su, Weijia Lu, Yexuan Guo, Zhuoyi Liu, Xu Wang, Hong Yan, Rui Xue Zhang. (2023) Depot unilamellar liposomes to sustain transscleral drug Co-delivery for ophthalmic infection therapy. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, [PMID:] [10.1016/j.jddst.2023.104629] |
| 3. Hang Hu, Jiyao Zhang, Yulan Huang, Deng Wang, Dongyang Li, Jiabang Chen, Jiawen Wu, Luozheng Zhang, Xianyong Zhou, Bihua Hu, Xingzhu Wang, Jianyong Ouyang, Baomin Xu. (2022) Small Molecule Passivation Leading to Efficient Hole Transport Layer-Free Sn–Pb Mixed Perovskite Solar Cells with High Open-Circuit Voltage. Solar RRL, 6 (12): (2200721). [PMID:] [10.1002/solr.202200721] |
| 4. Wenjuan Huang, Liwen Wang, Ruhui Yang, Ronggui Hu, Qinxiang Zheng, Xingjie Zan. (2022) Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy. Materials Today Bio, [PMID:36281304] [10.1016/j.mtbio.2022.100456] |
| 5. Xueling Yi, Zhilang Xu, Qisong Liu, Hongmei Zhou, Lun Yuan, Defu Li, Lei Zhao, Changdao Mu, Liming Ge. (2022) Matrix metalloproteinase-responsive collagen-oxidized hyaluronic acid injectable hydrogels for osteoarthritic therapy. Biomaterials Advances, [PMID:35929283] [10.1016/j.bioadv.2022.212804] |
| 6. Zhen-Hua Ying, Hui-Min Li, Wen-Ying Yu, Chen-Huan Yu. (2021) Iridin Prevented Against Lipopolysaccharide-Induced Inflammatory Responses of Macrophages via Inactivation of PKM2-Mediated Glycolytic Pathways. Journal of Inflammation Research, [PMID:33574693] [10.2147/JIR.S292244] |
| 7. Qin Wang, Liming He, Donghao Fan, Wenlang Liang, Xiaochen Wang, Jiyu Fang. (2020) PLA2-Triggered Release of Drugs from Self-Assembled Lipid Tubules for Arthritis Treatments. ACS Applied Bio Materials, [PMID:35021780] [10.1021/acsabm.0c00883] |
| 8. Liwen Wang, Shan Luo, Hongyan Xu, Xiaoxiao Wu, Pengyan Hao, Yagang Zhang, Wenjuan Huang, Xingjie Zan. (2020) Evaluation of His6-Metal Assemblies as a Drug Delivery Vehicle in the Treatment of Anterior Segment Disease Using a Corneal Inflammation Model. ACS Biomaterials Science & Engineering, [PMID:33463356] [10.1021/acsbiomaterials.0c00218] |
| 9. Zi-Han Xu, Ming-Min Xie, Chun-Lan Xie, Xian-Wen Yang, Jun-Song Wang. (2025) Deep-Sea-Derived Isobisvertinol Targets TLR4 to Exhibit Neuroprotective Activity via Anti-Inflammatory and Ferroptosis-Inhibitory Effects. Marine Drugs, 23 (1): (49). [PMID:39852551] [10.3390/md23010049] |
| 10. Kai Dong, Ying Zhang, Hong Rui Ji, Ze Lin Guan, Dan Yang Wang, Zi Yang Guo, Shu Jing Deng, Bin Yang He, Jian Feng Xing, Cui Yu You. (2024) Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites. International Journal of Nanomedicine, [PMID:38299194] [10.2147/IJN.S442369] |
| 11. Huang Suiyuan, Sun Xuehua, Xin Jianwei, Ma Panpan, Zhang Yuqi, Cai Zhongyu, Wang Ji-Jiang. (2025) Molecularly imprinted hydrogels embedded with two-dimensional photonic crystals for the detection of dexamethasone/betamethasone sodium phosphate. MICROCHIMICA ACTA, 192 (2): (1-11). [PMID:39878789] [10.1007/s00604-025-06981-w] |
| 12. Yaoting He, Ziyang Jin, YiFan Wang, Chengwei Wu, Xuzhao He, Wenjian Weng, Xiujun Cai, Kui Cheng. (2025) Multifunctional Double-Loaded Oral Nanoplatform for Computed Tomography Imaging-Guided and Integrated Treatment of Inflammatory Bowel Disease. ACS Nano, [PMID:40106686] [10.1021/acsnano.4c18865] |
| 13. Qinglian Hu, Jingyu Li, Tong Wang, Xiangchi Xu, Yuxuan Duan, Yuanxiang Jin. (2024) Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease. ACS Nano, [PMID:38720520] [10.1021/acsnano.4c00830] |
| 14. Yuanwei He, Ziyu Chen, Qinglang Liu, Zhiyang Li, Dingsheng Wen, Hong Zhang, Ming Zhang, Di Jiang, Huaan Li, Lu Wen, Gang Chen. (2024) Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases. JOURNAL OF CONTROLLED RELEASE, [PMID:38906419] [10.1016/j.jconrel.2024.06.043] |
| 15. Jiayi Shi, Xuekai Qi, Ying Ran, Qiang Zhou, Yiqin Ding, Lujian Li, Youyun Zeng, Dongchao Qiu, Zhibin Cai, Xiaojun Cai, Yihuai Pan. (2025) Saliva-acquired pellicle inspired multifunctional gargle with wet adhesion, photodynamic antimicrobial, and In situ remineralization properties for dental caries prevention. Bioactive Materials, [PMID:39906646] [10.1016/j.bioactmat.2025.01.008] |
| 16. Hang-yi Hu, Ying-jian Sun, Xiao-feng Yuan, Jiang-fan Han, Tian-tian Liao, Fei-yue Zhang, Jin-dong Mao, Lin Zhang, Wei-liang Ye. (2025) Ultrasound-controllable dexamethasone-loaded nanobubbles for highly effective rheumatoid arthritis therapy. Journal of Materials Chemistry B, [PMID:39757977] [10.1039/D4TB01120A] |
| 17. Yaqi Zhang, Shiyao Liu, Hongman Xu, Jiahui Wu, Ruquan Zhang, Yongzhen Tao. (2026) Electric, pH, and Mechanical Stimuli-Responsive Hydrogels from Methacrylated Pullulan and Carboxymethylated-Methacrylated Xanthan Gum as Drug Carriers. ACS Applied Polymer Materials, [PMID:] [10.1021/acsapm.5c04449] |
| 18. Zi-Han Xu, Zheng-Biao Zou, Chun-Xiu Wang, Chen Li, Xian-Wen Yang, Jun-Song Wang. (2026) Anti-Neuroinflammatory Naphtho-γ-Pyrones from a Deep-Sea-Derived Fungus Aspergillus niger 3A00562. Marine Drugs, 24 (4): (125). [PMID:] [10.3390/md24040125] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →